Synedgen Company
.jpg)
Synedgen develops novel therapies and products to reduce infection and inflammation of dermal, oral, mucosal, and ophthalmic surfaces.
Total Funding:
$15 890 877
Number Of Exists:
N/A
Investor Type:
N/A
Employee Number:
11-50
Last Funding Date:
2020-01-29
Funding Status:
undisclosed
Technology:
Preventive Medicine
Estimated Revenue:
$1M to $10M
Founded Date:
2009-01-01
Industry:
PharmTech
Investment Stage:
N/A
Headquarters:
Claremont, California, United States
Last Funding Type:
Venture - Series Unknown